Summary
An increase of low-density lipoprotein triglycerides (LDL-Tg) was found to be an independent coronary artery disease (CAD) risk factor for non-insulin-dependent diabetic (NIDDM) patients in a recent prospective study. We examined the composition and size of LDL particles in 50 NIDDM men with angiographically verified CAD (NIDDM+ CAD+) and in 50 NIDDM men without CAD (NIDDM+ CAD−) as compared to 50 non-diabetic men with CAD (NIDDM− CAD+) and 31 non-diabetic men without CAD (NIDDM− CAD−). The groups had similar ranges of age and BMI LDL particle size was determined by gradient gel electrophoresis, and LDL was isolated by sequential ultracentrifugation for compositional analyses. Serum Tg was increased in NIDDM patients as compared to non-diabetic subjects (p<0.05), and in patients with CAD as compared to subjects without the disease (p<0.05). LDL cholesterol was lower in NIDDM patients than in non-diabetic subjects (p<0.001). Mean diameter of LDL particles was less than 255 å, but closely comparable in all groups. The presence of NIDDM was associated with increases of Tg and protein but lowering of free cholesterol in LDL (p<0.005 for all). In multivariate regression analyses neither NIDDM nor CAD were associated with LDL particle size, but serum Tg was the major determinant of LDL size in both NIDDM and non-diabetic subjects (p<0.001). When the patients were divided into quartiles according to fasting serum Tg levels, the LDL particle size and free cholesterol content decreased, but Tg and protein contents of LDL particles increased from the lowest to the highest Tg quartile (analysis of variance p<0.001 for all). When the subjects were categorized into two groups according to the median of VLDL-Tg (1.10 mmol/l) LDL size was associated with VLDL-Tg in the high but not in the low VLDL-Tg group. We conclude that in NIDDM patients with or without CAD serum Tg is the major determinant of the properties of LDL particles. The clinical implication is that in NIDDM serum Tg should be as low as possible to prevent atherogenic changes in LDL.
Similar content being viewed by others
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- CAD:
-
coronary artery disease
- HDL:
-
high-density lipoprotein
- LDL:
-
low-density lipoprotein
- VLDL:
-
very-low-density lipoprotein
- apoB:
-
apolipoprotein B
- HL:
-
hepatic lipase
- LPL:
-
lipoprotein lipase
- CETP:
-
cholesteryl ester transfer protein
- PL:
-
phospholipids
- ANOVA:
-
analysis of variance
- Tg:
-
triglycerides
- FC:
-
free cholesterol
References
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham Study. JAMA 241: 2035–2038
Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676–1685
Wingard DL, Barrett-Connor E, Criqui MH, Suarez L (1983) Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 117: 19–26
PyörÄlÄ K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3: 463–524
Stamler J, Vaccaro O, Neaton JD, Wenthworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16: 434–444
Howard BJ (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613–628
Taskinen M-R (1990) Hyperlipidemia in diabetes. Clin Endocrinol Metab 4: 743–775
Taskinen M-R (1992) Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 [Suppl 2]: 12–17
Pfeiffer MA, Brunzell JD, Best JD, Judgewitsch RG, Halter JB, Porte D Jr (1983) The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes 32: 525–531
Fontbonne A, Eschwege E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300–304
Laakso M, Lehto S, PenttilÄ I, PyörÄlÄ K (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88 [Part 1]: 1421–1430
Fisher WJ (1983) Heterogeneity of plasma low density lipoproteins; manifestations of the physiologic phenomenon in man. Metabolism 32: 283–291
Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23: 97–104
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917–1921
Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495–506
Campos H, Blijlevens E, McNamara JR et al. (1992) LDL particle size distribution. Results from the Framingham offspring study. Arterioscler Thromb 12: 1410–1419
Barrett-Connor E, Grundy SM, Holdbrook MJ (1982) Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115: 657–663
Rönnemaa T, Laakso M, Kallio V, PyörÄlÄ K, Marniemi J, Puukka P (1989) Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients. Am J Epidemiol 130: 632–645
Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, PyörÄlÄ K (1993) Ten-year cardiovasular mortality in relation to risk factor and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects. Diabetologia 36: 1175–1184
Tilly-Kiesi M, SyvÄnne M, Kuusi T, LahdenperÄ S, Taskinen M-R (1992) Abnormalities of low-density lipoproteins in normolipidemic type 2 diabetic and non-diabetic patients with coronary heart disease. J Lipid Res 33: 333–342
Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4: 225–231
Barakat HA, Carpenter JW, McLendon VD et al. (1990) Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39: 1527–1533
Coresh J, Kwiterovich PO, Smith HH, Bachorik PS (1993) Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34: 1687–1697
McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ (1987) Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham offspring study. Arteriosclerosis 7: 483–490
SyvÄnne M, Kahri J, Virtanen KS, Taskinen M-R (1995) High density lipoproteins containing apolipoproteins A-I and A-II (LpA-I∶A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation (in press)
World Health Organization (1980) WHO Expert Committee on Diabetes Mellitus, Second Report. Geneva, World Health Organization, (Techn. Rep. Ser., no. 646)
Kupari M, Virtanen KS, Turto H et al. (1992) Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 70: 635–640
Havel JR, Eder HA, Bragdon JH (1955) Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Taskinen M-R, Kuusi T, Helve E, NikkilÄ E, Yki-JÄrvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis 8: 168–177
Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturing polyacrylamide gel electrophoresis. In: Segrest JP, Albers JJ (eds). Methods in enzymology: plasma lipoproteins. Vol. 128. Academic Press London, p. 417
LahdenperÄ S, Tilly-Kiesi M, Vuorinen-Markkola H, Kuusi T, Taskinen M-R (1993) Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 16: 584–592
Huttunen JK, Ehnholm C, Kinnunen PJ, NikkilÄ EA (1975) An immunochemical method for measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63: 335–347
Groener JEM, Pelton RW, Kostner GM (1986) Improved estimation of cholesteryl ester transfer activities. Clin Chem 32: 283–286
Kahri J, SyvÄnne M, Taskinen M-R (1994) Plasma cholesteryl ester transfer protein activity in NIDDM patients with and without coronary artery disease. Metabolism 43: 1498–1502
Kashyap MR, Hynd BA, Robinson K (1980) A rapid and simple method for measurement of total protein in very low density lipoprotein by the Lowry assay. J Lip Res 21: 491–495
SyvÄnne M, Ahola M, LahdenperÄ S et al. (1995) High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lip Res 36: 573–582
Feingold KR, Grunfeld C, Coerrler W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12: 1496–1502
Haffner SM, MykkÄnen L, Stern MP, Paidi M, Howard BV (1994) Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17: 1164–1171
Griffin BA, Freeman DJ, Tait GW et al. (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart risk. Atherosclerosis 106: 241–253
Pometta D, James RW (1993) Factors affecting lipoprotein in diabetes. International symposium on the lipid triad (triglycerides, HDL, LDL) and cardiovascular diseases. Milan, Italy July 5–8, 1993 (Abstract)
American Diabetes Association (1993) Detection and management of lipid disorders in diabetes. Diabetes Care 16: 828–834
NIH Consensus Development Panel (1993) Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269: 505–510
Manzato E, Zambon S, Zambon A, Cortella A, Sartore G, Grepaldi G (1993) Levels and physiochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. Clin Chem Acta 219: 57–65
Cohen JC, Grundy SM (1993) Normal postprandial lipemia in men with low plasma HDL concentrations. Arterioscler Thromb 12: 972–975
Taskinen M-R, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39: 1017–1027
Packard CJ, Gaw A, Demant T, Shepherd J (1995) Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J Lipid Res 36: 172–187
Nigon F, Lesnik P, Rouis M, Chapman MJ (1991) Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 32: 1741–1753
Lagrost L, Gambert P, Lallemant C (1994) Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 14: 1327–1336
Taskinen M-R (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology 6: 153–160
McKeone BJ, Patsch JR, Pownall HJ (1993) Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest 91: 1926–1933
Chait A, Brazg RL, Tribble DL, Krauss RM (1993) Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94: 350–356
Galeano NF, Milne R, Marcel YL et al. (1994) Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 269: 511–519
Fielding CJ, Reaven GM, Liu G, Fielding PE (1984) Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci 81: 2512–2516
Owens D, Maher V, Collins P, Johnson A, Tomkin GH (1990) Cellular cholesterol regulation — a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologia 33: 93–99
Kuksis A, Myher JJ, Geher K et al. (1982) Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease. Arteriosclerosis 2: 296–302
Vakakis N, Redgrave TG, Small DM, Castelli WP (1983) Cholesterol content of red blood cells and low density lipoproteins in hypertriglyceridemia. Biochim Biophys Acta 751: 280–285
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LahdenperÄ, S., SyvÄnne, M., Kahri, J. et al. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 39, 453–461 (1996). https://doi.org/10.1007/BF00400677
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400677